Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=Person:%22Flannery%2C+Patrick+C%22
/vufind/Search/Results?lookfor=Person:%22Flannery%2C+Patrick+C%22
Search /vufind/Search2/Results?lookfor=Person:%22Flannery%2C+Patrick+C%22
PubPharm (20)
1
Gefitinib Inhibits Rifampicin-Induced CYP3A4 Gene Expression in Human Hepatocytes
enthalten in:
ACS omega
| 2022
von
Abbott, K.
|
Salamat, J.
|
Flannery, P.
| +7
Wird geladen...
2
Interplay between the Cannabinoid System and microRNAs in Cancer
enthalten in:
ACS omega
| 2022
von
Salamat, J.
|
Abbott, K.
|
Flannery, P.
| +2
Wird geladen...
3
A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice
enthalten in:
Liver research
| 2021
von
Pondugula, S.
|
Salamat, J.
|
Abbott, K.
| +16
Wird geladen...
4
Oroxylum indicum extract, at a physiologically relevant dosage, does not induce hepatotoxicity in C57BL/6J mice
enthalten in:
Natural product communications
| 2021
von
Pondugula, S.
|
Salamat, J.
|
Abbott, K.
| +17
Wird geladen...
5
Dysregulation of Endobiotic Homeostasis Mechanisms : Novel Insights into Adverse Pharmacokinetic Interactions between Illicit Substances and Clinical Drugs
enthalten in:
ACS chemical neuroscience
| 2020
von
Salamat, J.
|
Abbott, K.
|
Flannery, P.
| +1
Wird geladen...
6
Nothing Ventured, Nothing Gained : Regulations Cripple Potentially Life-Saving Research of Illicit Substances
enthalten in:
ACS chemical neuroscience
| 2020
von
Abbott, K.
|
Gill, K.
|
Flannery, P.
| +3
Wird geladen...
7
Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients
enthalten in:
European journal of drug metabolism and pharmacokinetics
| 2020
von
Flannery, P.
|
Abbott, K.
|
Pondugula, S.
Wird geladen...
8
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
enthalten in:
Drug metabolism reviews
| 2020
von
Abbott, K.
|
Flannery, P.
|
Gill, K.
| +4
Wird geladen...
9
Adverse pharmacokinetic interactions between illicit substances and clinical drugs
enthalten in:
Drug metabolism reviews
| 2020
von
Abbott, K.
|
Flannery, P.
|
Gill, K.
| +4
Wird geladen...
10
Gefitinib, at Its Clinically Relevant Concentrations, Inhibits Rifampicin‐Induced CYP3A4 Gene Expression in Human Hepatocytes
enthalten in:
The FASEB Journal
| 2020
von
Abbott, K.
|
Salamat, J.
|
Flannery, P.
| +6
Wird geladen...
1
2
Nächster »
[2]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
20
Aufsätze
17
E-Artikel
17
E-Ressourcen
3
Gedruckte Aufsätze
Zeitschriftentitel
4
European journal of drug metabolism and pharmac...
2
ACS chemical neuroscience
2
ACS omega
2
Cancer letters
2
Drug metabolism reviews
2
The FASEB Journal
2
Toxicology letters
1
Drug metabolism and disposition: the biological...
1
Liver research
1
Natural product communications
1
Oncology reports
Alle anzeigen ...
weniger ...
Thema
12
Journal Article
6
Research Support, Non-U.S. Gov't
4
Cytochrome P-450 CYP3A
4
EC 1.14.14.1
4
MDMA
4
Pregnane X Receptor
4
cannabis
3
CYP3A4 protein, human
3
EC 1.14.14.55
3
Receptors, Steroid
3
adverse drug interactions
2
Antineoplastic Agents
2
CYP
2
CYP3A4
2
Comparative Study
2
Cytotoxicity
2
Diindolylmethane
2
EC 3.1.3.16
2
Illicit Drugs
2
Illicit substances
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
10
2020-
10
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
18
Englisch
Haven't found what you're looking for?
Wird geladen...
